BR9508645A - Vacina da peritonite infecciosa felina - Google Patents
Vacina da peritonite infecciosa felinaInfo
- Publication number
- BR9508645A BR9508645A BR9508645A BR9508645A BR9508645A BR 9508645 A BR9508645 A BR 9508645A BR 9508645 A BR9508645 A BR 9508645A BR 9508645 A BR9508645 A BR 9508645A BR 9508645 A BR9508645 A BR 9508645A
- Authority
- BR
- Brazil
- Prior art keywords
- infectious peritonitis
- feline infectious
- vaccine
- gene
- plasmids
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 208000005098 feline infectious peritonitis Diseases 0.000 title abstract 2
- 241000700605 Viruses Species 0.000 abstract 2
- 239000013613 expression plasmid Substances 0.000 abstract 2
- 102000035118 modified proteins Human genes 0.000 abstract 2
- 108091005573 modified proteins Proteins 0.000 abstract 2
- 241000711475 Feline infectious peritonitis virus Species 0.000 abstract 1
- 241000282326 Felis catus Species 0.000 abstract 1
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 101150010882 S gene Proteins 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 238000010276 construction Methods 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000013612 plasmid Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
- G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
- G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
- C12N2710/24141—Use of virus, viral particle or viral elements as a vector
- C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/20011—Coronaviridae
- C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9410379A FR2724385B1 (fr) | 1994-08-29 | 1994-08-29 | Vaccin de la peritonite infectieuse feline. |
| PCT/FR1995/001128 WO1996006934A1 (fr) | 1994-08-29 | 1995-08-28 | Vaccin de la peritonite infectieuse feline |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR9508645A true BR9508645A (pt) | 1997-12-23 |
| BR9508645B1 BR9508645B1 (pt) | 2009-01-13 |
Family
ID=9466540
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI9508645-5A BR9508645B1 (pt) | 1994-08-29 | 1995-08-28 | seqÜÊncia de nucleotÍdeos isolada compreendendo o gene s fipv tendo uma seqÜencia de nucleotÍdeos da cepa 79-1146 fipv, bem como polipeptÍdeo, vacina e composiÇço compreendendo a mesma. |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US6080850A (pt) |
| EP (1) | EP0778894B1 (pt) |
| JP (1) | JPH10505236A (pt) |
| AT (1) | ATE323767T1 (pt) |
| AU (1) | AU686000B2 (pt) |
| BR (1) | BR9508645B1 (pt) |
| CA (1) | CA2198743C (pt) |
| DE (1) | DE69534945T2 (pt) |
| DK (1) | DK0778894T3 (pt) |
| ES (1) | ES2264128T3 (pt) |
| FR (1) | FR2724385B1 (pt) |
| PT (1) | PT778894E (pt) |
| WO (1) | WO1996006934A1 (pt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2751223B1 (fr) * | 1996-07-19 | 1998-12-04 | Rhone Merieux | Formule de vaccin polynucleotidique felin |
| WO1998027433A1 (en) * | 1996-12-18 | 1998-06-25 | Engene Biotechnologies, Inc | A specific diagnostic for antibodies to feline infectious peritonitis virus |
| FR2828405B1 (fr) * | 2001-08-09 | 2005-06-24 | Virbac Sa | Vaccin anti-coronavirus |
| US8080642B2 (en) * | 2003-05-16 | 2011-12-20 | Vical Incorporated | Severe acute respiratory syndrome DNA compositions and methods of use |
| WO2013123242A1 (en) | 2012-02-14 | 2013-08-22 | Merial Limited | Recombinant poxviral vectors expressing both rabies and ox40 proteins, and vaccines made therefrom |
| CN116808193B (zh) * | 2023-08-29 | 2023-11-14 | 成都导飞科技有限公司 | 一种用于预防猫传染性腹膜炎的重组蛋白疫苗及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0264979A1 (en) * | 1986-09-05 | 1988-04-27 | Duphar International Research B.V | New antigenically active proteins and peptides, and feline infectious peritonitis virus (FIPV) vaccines |
| US5410472A (en) * | 1989-03-06 | 1995-04-25 | Ergometrx Corporation | Method for conditioning or rehabilitating using a prescribed exercise program |
| AU634010B2 (en) * | 1989-11-28 | 1993-02-11 | Toyo Seikan Kaisha Ltd. | Metallic container equipped with hologram or diffraction grating |
| EP0640097A4 (en) * | 1992-05-08 | 1997-01-15 | Smithkline Beecham Corp | COMPOSITION AND METHODS FOR VACCINATING AGAINST CORONAVIRES (01/20/94). |
| GB2282601B (en) * | 1993-09-16 | 1998-04-15 | Solvay | Antigenically-active proteins/polypeptides and coronavirus vaccines containing the same |
-
1994
- 1994-08-29 FR FR9410379A patent/FR2724385B1/fr not_active Expired - Lifetime
-
1995
- 1995-08-28 AU AU32612/95A patent/AU686000B2/en not_active Expired
- 1995-08-28 BR BRPI9508645-5A patent/BR9508645B1/pt active IP Right Grant
- 1995-08-28 DK DK95929143T patent/DK0778894T3/da active
- 1995-08-28 AT AT95929143T patent/ATE323767T1/de active
- 1995-08-28 CA CA002198743A patent/CA2198743C/en not_active Expired - Lifetime
- 1995-08-28 PT PT95929143T patent/PT778894E/pt unknown
- 1995-08-28 WO PCT/FR1995/001128 patent/WO1996006934A1/fr active IP Right Grant
- 1995-08-28 US US08/519,979 patent/US6080850A/en not_active Expired - Fee Related
- 1995-08-28 EP EP95929143A patent/EP0778894B1/fr not_active Expired - Lifetime
- 1995-08-28 JP JP8508535A patent/JPH10505236A/ja active Pending
- 1995-08-28 DE DE69534945T patent/DE69534945T2/de not_active Expired - Lifetime
- 1995-08-28 ES ES95929143T patent/ES2264128T3/es not_active Expired - Lifetime
-
1998
- 1998-11-20 US US09/196,187 patent/US6096535A/en not_active Expired - Fee Related
-
2000
- 2000-06-13 US US09/592,991 patent/US6358512B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US6358512B1 (en) | 2002-03-19 |
| WO1996006934A1 (fr) | 1996-03-07 |
| EP0778894B1 (fr) | 2006-04-19 |
| FR2724385B1 (fr) | 1996-12-13 |
| DE69534945T2 (de) | 2007-02-01 |
| AU686000B2 (en) | 1998-01-29 |
| CA2198743C (en) | 2009-02-10 |
| AU3261295A (en) | 1996-03-22 |
| BR9508645B1 (pt) | 2009-01-13 |
| US6096535A (en) | 2000-08-01 |
| JPH10505236A (ja) | 1998-05-26 |
| FR2724385A1 (fr) | 1996-03-15 |
| CA2198743A1 (en) | 1996-03-07 |
| DK0778894T3 (da) | 2006-08-07 |
| ATE323767T1 (de) | 2006-05-15 |
| EP0778894A1 (fr) | 1997-06-18 |
| DE69534945D1 (de) | 2006-05-24 |
| ES2264128T3 (es) | 2006-12-16 |
| US6080850A (en) | 2000-06-27 |
| PT778894E (pt) | 2006-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69737886D1 (de) | Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays | |
| CY1106806T1 (el) | Dna και πολυπεπτιδια ανθρωπινης tslp | |
| DK0870046T3 (da) | Levende rekombinant vaccine som indeholder felint herpesvirus type 1, især til behandling af felin infektiös peritonitis | |
| CY1107720T1 (el) | Ιος συνδρομου πολυσυστηματικης απισχνανσεως μετα τον απογαλακτισμο απο χοιρους | |
| ATE335831T1 (de) | Nukleinsäurevektor, einen solchen vektor enthaltene verbindung und impfstoff zur immunisierung gegen hepatitis | |
| DE69536039D1 (de) | Wirtszelle enthaltend ein rekombinantes Virus, welches ein Antigen exprimiert und ein rekombinantes Virus, welches ein immunstimulatorisches Molekül exprimiert | |
| ES8500322A1 (es) | Un metodo de modificar un virus para conferirle una nueva funcion biologica. | |
| ATE329616T1 (de) | Virale nukleotidsequenz vr-2332 und nutzungsverfahren | |
| DE69837708D1 (de) | Von alphavirus abgeleitete vektoren als impfstoffe gegen eine paramyxovirusinfektion | |
| ATE328073T1 (de) | Ehrlichia canis protein | |
| DE69131903D1 (de) | Klonierung hühner-anaemia-virus-dna | |
| MX9202512A (es) | Virus de avipox recombinante, cultivo de celulas infectadas por este virusy vacunas para las aves de corral derivadas de este virus. | |
| ES2188605T3 (es) | Virus poxvirales y su utilizacion como vacuna contra la enfermedad virica de la peritonitis infecciosa felina. | |
| BR9508645A (pt) | Vacina da peritonite infecciosa felina | |
| AR009365A1 (es) | Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno | |
| CY1116756T1 (el) | Αιμοκυανινη και κωδικευουσα γι'αυτην ακολουθια νουκλεϊνικου οξεος | |
| FR2828405B1 (fr) | Vaccin anti-coronavirus | |
| ES2073777T3 (es) | Inhibicion de la replicacion virica. | |
| DK0691404T3 (da) | Vaccine til immunisering mod TBE-virusinfektioner samt en fremgangsmåde til fremstilling deraf | |
| BR0010222A (pt) | Vetores de expressão viral | |
| BR0012556A (pt) | Genes e vacinas de ehrlichia canis | |
| Darteil et al. | Feline infectious peritonitis vaccine | |
| DE50304603D1 (de) | Impfstoff gegen infektionen mit onkoviren, wie dem felinen leukosevirus der katze | |
| CY1108761T1 (el) | Απενεργοποιημενες κυτοκινες για ανοσοποιηση | |
| ATE269064T1 (de) | Impfstoffe gegen den hepatitis b und c virus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| TC | Change of name | ||
| FB36 | Technical and formal requirements: requirement - article 36 of industrial property law | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 25/02/2009, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B22O | Other matters related to patents and certificates of addition of invention: legal action concerning patent |
Free format text: INPI-52400.061601/2013 ORIGEM: JUIZO DA 013A VARA FEDERAL DO RIO DE JANEIRO PROCESSO NO 0132345-04.2013.4.02.5101 ACAO DE NULIDADE DAS PATENTES SUBMETIDAS AO MAILBOX (ART. 229, PARAGRAFO UNICO DA LPI); ALTERNATIVAMENTE, A DECRETACAO DA NULIDADE PARCIAL PARA CORRECAO DO PRAZO DE VIGENCIA; SUBSIDIARIAMENTE, CASO SE ENTENDA NAO SER O CASO DE NULIDADE, A CORRECAO DO ATO ADMINISTRATIVO PARA ADEQUACAO DA VIGENCIA DAS PATENTES. AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL - INPI REU: MERIAL, SCHERING CORPORATION, FLAMEL TECHNOLOGIES E WARNER-LAMBERT COMPANY LLC |
|
| B19A | Notification of judicial decision: notification of judicial decision |
Free format text: INPI-52400.061601/2013-11 SECAO JUDICIARIA DO RIO DE JANEIRO 31A VARA FEDERAL DO RIO DE JANEIRO PROCESSO: NO0132345-04.2013.4.02.5101 AUTOR: INSTITUTO NACIONAL DA PROPRIEDADE INDUSTRIAL ? INPI REU MERIAL, FLAMEL TECHNOLOGIES E MECNEIL - PPC DECISAO: ? O RECURSO DE APELACAO INTERPOSTO PELO INPI MERECE PROVIMENTO, PARA JULGAR PROCEDENTE O PEDIDO AUTORAL ALTERNATIVO E DECLARAR A PARCIAL DAS PATENTES PI 9506138-0, PI 9508645-5, PI 9702150-4, PI 9702151-2, DE TITULARIDADE DA 1A APELADA, MERIAL, E COM RELACAO A PATENTE PI 9509286-2, DE TITULARIDADE DA 2A APELADA FLAMEL TECHNOLOGIES E DETERMINAR A ADEQUACAO DO SEU PRAZO DE VIGENCIA AS REGRAS DO ART. 229, PARAGRAFO UNICO C/C ART. 40, CAPUT DA LPI |